Imaging support for apollo 5, moonshot
Active Awarded Last action
- Contract number
- 75N91019F00131
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,749,238
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $7,749,238.21 Current and potential, with all options
- Completion date 94% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$1,000,070 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $8,749,308 |
About this award
This is a federal contract award to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., by the National Cancer Institute (NCI). The contract, valued at $7,749,238.21, is for imaging support services for the Apollo 5 Moonshot program, which is part of the President's Department of Government Efficiency Cost Efficiency Initiative. The contract type is a Delivery Order with a Cost Plus Fixed Fee pricing structure, and the ultimate completion date is April 14, 2027. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing comprehensive biomedical research and facilities support services to federal agencies, with a focus on the National Institutes of Health (NIH).
Quick answers
Who was awarded contract 75N91019F00131?
75N91019F00131 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on April 15, 2019.
How much is contract 75N91019F00131 worth?
The government has obligated $7,749,238 on 75N91019F00131.
Is contract 75N91019F00131 an order under another contract?
Yes. 75N91019F00131 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91019F00131 competed?
The extent of competition for 75N91019F00131 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award